Testing the effectiveness of a social prescription and virtual patient information in increasing tertiary prevention among cancer patients

Not Applicable

Conditions: Cancer Patients

Registration Number: DRKS00033771

Lead Sponsor: niversität Regensburg

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 90

Inclusion Criteria

The study will include German speaking adult patients (aged =18 years) attending medical oncology units at the participating hospital, diagnosed with early-stage or advanced cancer (i. e., cancer stages I to IV) no more than 6 months ago, who have an expected survival of at least two years and will have provided written informed consent.
Support persons will also be included if they are German speaking, aged =18 years and nominated by the patient as someone helping them cope with their cancer through support, encouragement and communication, and will have provided written informed consent.

Exclusion Criteria

Key exclusion criteria involve inability to complete surveys or interviews independently (e. g., speech, vigilance).

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
(1) Uptake of physical activity of cancer patients (measured using accelerometers within 4 weeks);<br>(2) Uptake of participation in social activities and psychosocial support (measured with the social activity log and self-report on use of psychosocial support); <br>Time of data collection: Baseline, Follow-up after 3, 6, 12 months

Secondary Outcome Measures

Name	Time	Method
(3) Quality of life (measured using EORTC QLQ-C15-PAL);<br>(4) Knowledge of the benefits of physical activity and psychosocial support (measured using self-designed questions); <br>(5) Self-efficacy (measured using CBI-B-D);<br>(6) Cost-effectiveness<br>(7) Time spent in the consultation<br>(8) Potential implementation barriers and enablers of the intervention (interviews)<br>Time of data collection: Baseline, Follow-up after 3, 6, 12 months